Live feed16:10:09·947dSECFilingvia QuantisnowRecro Pharma Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.REPH· Recro Pharma Inc.Health CareOriginal source
